Ireland· IE-PA-PA1350/008/001
Cifoban 136 mmol/l solution for infusion
A hemofiltrates product containing trisodium citrate dihydrate, registered in Ireland by Fresenius Medical Care Deutschland GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Trisodium citrate dihydrate is registered in 11 of 19 countries.
Countries holding a registration under ATC B05ZB (hemofiltrates), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Trisodium citrate dihydrate · ATC B05ZB
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Trisodium citrate dihydrate
- Manufacturer
- Fresenius Medical Care Deutschland GmbH
- Country
- Ireland (IE)
- ATC code
- B05ZB
- ATC class
- Hemofiltrates
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1350/008/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trisodium citrate dihydrate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCivastyn 136 mmol/lFresenius Medical Care Deutschland
- United StatesAnticoagulant Sodium CitrateCSL Plasma Inc.
- CzechiaCIGENTAFresenius Medical Care Deutschland GmbH, Bad Homburg
- NetherlandsCifoban 136 mmol/l oplossing voor infusieFresenius Medical Care Deutschland GmbH
- FinlandCifobanFresenius Medical Care Deutschland GmbH
- CanadaANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USPBAXTER CORPORATION
- United KingdomSoltran solution 1litre Viaflex bagsBaxter Healthcare Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Canesoasis Cystitis Relief, Care Cystitis Relief
- Italy · Sodio Citrato S.A.L.F.
- Portugal · Citrato De Sódio 3,8%, Citrato De Sódio 5,0%
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95d51516-a056-4fbe-a499-508d33ff997c GET /v1/drugs/95d51516-a056-4fbe-a499-508d33ff997c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B05ZB"
],
"strength": null,
"pa_number": "PA1350/008/001",
"substances": [
"Trisodium citrate dihydrate"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "28/01/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about trisodium citrate dihydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.